Net Income Attributed to Kopin Corporation for the third quarter of 2025 was $4.1 million, or $0.02 per share, compared with a net loss of ($3.5) million, or ($0.03) per share, for the Third Quarter ...
A number of local veterans and their families gathered on the blustery, cold morning of Tuesday, Nov. 11, 2025, at the ...
Kisco Senior Living has launched a new memory care model grounded in scientific research and Montessori-based principles. Last year, the Carlsbad, ...
Company reports Q3 2025 AUCATZYL® net product revenue of $21.1 million and deferred revenue of $7.6 million; 60 authorized treatment centers achieved ahead of targetClinical execution and data ...
"India is entering a decisive phase in its science and technology journey. Our goal is not just to expand research output, ...
Q2 2026 Earnings Call November 12, 2025 4:00 AM ESTCompany ParticipantsSam GhezelbashSimon Michel - CEO & Member of ...
ProMIS Neurosciences Inc. , a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases, ...
Armata Pharmaceuticals, Inc. ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback